Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )
Articles Source Posted
Billing and Coding: MolDX: HEXA Gene Analysis (A55255) Retirement - Effective May 8, 2024 may 16, 2024
Billing and Billing and Coding: MolDX: BCKDHB Gene Test (A55099) Retirement - Effective May 8, 2024 may 16, 2024
Billing and Coding: MolDX: IKBKAP Genetic Testing (A55612) Retirement - Effective May 7, 2024 may 16, 2024
Self-Administered Drug Exclusion List (A53032) - R35 - Effective June 23, 2024 may 09, 2024
Billing and Coding: MolDX: TP53 Gene Tests (A55484) Retirement - Effective May 1, 2024 may 09, 2024
Billing and Coding: MolDX: TERC Gene Tests (A55611) Retirement - Effective May 1, 2024 may 09, 2024
Billing and Coding: MolDX: RPS19 Gene Tests (A55610) Retirement - Effective April 30, 2024 may 09, 2024
Billing and Coding: MolDX: NSD1 Gene Tests (A55609) Retirement - Effective April 30, 2024 may 09, 2024
Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers - Published for Review and Comments may 02, 2024
MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services (A59743) - Effective May 2, 2024 may 02, 2024
Billing and Coding: MolDX: Prometheus® IBD sgi Diagnostic® Policy (A57516) - R3 - Effective October 20, 2022 may 02, 2024
Billing and Coding: MolDX: KIF6 Genotype (A55272) Retirement - Effective April 26, 2024 may 02, 2024
Billing and Coding: MolDX: MECP2 Genetic Testing (A55285) Retirement - Effective April 26, 2024 may 02, 2024
Billing and Coding: MolDX: CHD7 Gene Analysis (A55085) Retirement - Effective April 25, 2024 may 02, 2024
Billing and Coding: MolDX: STAT3 Gene Testing (A55480) Retirement - Effective April 24, 2024 may 02, 2024
Billing and Coding: MolDX: Know Error® (A55274) Retirement - Effective April 24, 2024 may 02, 2024
Billing and Coding: MolDX: PTCH1 Gene Testing (A55608) Retirement - Effective April 25, 2024 may 02, 2024
Multi-Jurisdictional CAC Meeting Announcement - MolDX: Biomarker Risk Stratification Testing in DCIS - July 15, 2024, 2 p.m. to 4 p.m. ET abr 30, 2024
Open Meeting Announcement Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers - May 16, 2024 abr 25, 2024
Billing and Coding: MolDX: ATP7B Gene Tests (A55097) Retirement - Effective April 23, 2024 abr 25, 2024